Literature DB >> 23886561

Improved dual promotor-driven reverse genetics system for influenza viruses.

Ahmed Mostafa1, Pumaree Kanrai, John Ziebuhr, Stephan Pleschka.   

Abstract

Reverse genetic systems for influenza A virus (IAV) allow the generation of genetically manipulated infectious virus from a set of transfected plasmid DNAs encoding the eight genomic viral RNA segments (vRNA). For this purpose, cDNAs representing these eight vRNA segments are cloned into specific plasmid vectors that allow the generation of vRNA-like transcripts using polymerase I (Pol I). In addition, these plasmids support the transcription of viral mRNA by polymerase II (Pol II), leading to the expression of viral protein(s) encoded by the respective transcripts. In an effort to develop this system further, we constructed the bi-directional vector pMPccdB. It is based on pHW2000 (Hoffmann et al., 2000b) but contains additionally (i) the ccdB gene whose expression is lethal for most Escherichia coli strains and therefore used as a negative selection marker and (ii) more efficient AarI cloning sites that flank the ccdB gene on either side. Furthermore, we used a modified one-step restriction/ligation protocol to insert the desired cDNA into the respective pMPccdB vector DNA. Both the use of a negative selection marker and an improved cloning protocol were shown to facilitate the generation of genetically engineered IAV as illustrated in this study by the cloning and rescue of the 2009 pandemic isolate A/Giessen/6/2009 (Gi-H1N1).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BGH; Bovine growth hormone; CEF; Chicken embryo fibroblast; Cloning vector; FFU; Focus-forming units; Influenza virus; Pandemic; Pdm; Reverse genetic systems; recombinant generated; rg

Mesh:

Year:  2013        PMID: 23886561     DOI: 10.1016/j.jviromet.2013.07.021

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  14 in total

1.  Development and Characterization of a Reverse-Genetics System for Influenza D Virus.

Authors:  Jieshi Yu; Runxia Liu; Bin Zhou; Tsui-Wen Chou; Elodie Ghedin; Zizhang Sheng; Rongyuan Gao; Shao-Lun Zhai; Dan Wang; Feng Li
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

2.  Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.

Authors:  Wolfgang Nacken; Darisuren Anhlan; Eike R Hrincius; Ahmed Mostafa; Thorsten Wolff; Anne Sadewasser; Stephan Pleschka; Christina Ehrhardt; Stephan Ludwig
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

3.  In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses.

Authors:  Sonja Schmier; Ahmed Mostafa; Thomas Haarmann; Norbert Bannert; John Ziebuhr; Veljko Veljkovic; Ursula Dietrich; Stephan Pleschka
Journal:  Sci Rep       Date:  2015-06-19       Impact factor: 4.379

4.  Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.

Authors:  Nadine Eckert; Florian Wrensch; Sabine Gärtner; Navaneethan Palanisamy; Ulrike Goedecke; Nils Jäger; Stefan Pöhlmann; Michael Winkler
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

5.  Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments.

Authors:  Ahmed Mostafa; Pumaree Kanrai; Henning Petersen; Sherif Ibrahim; Silke Rautenschlein; Stephan Pleschka
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

6.  Bacterial ribonuclease binase exerts an intra-cellular anti-viral mode of action targeting viral RNAs in influenza a virus-infected MDCK-II cells.

Authors:  Raihan Shah Mahmud; Ahmed Mostafa; Christin Müller; Pumaree Kanrai; Vera Ulyanova; Yulia Sokurenko; Julia Dzieciolowski; Irina Kuznetsova; Olga Ilinskaya; Stephan Pleschka
Journal:  Virol J       Date:  2018-01-05       Impact factor: 4.099

7.  Ribonuclease from Bacillus Acts as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses.

Authors:  Raihan Shah Mahmud; Christin Müller; Yulia Romanova; Ahmed Mostafa; Vera Ulyanova; Stephan Pleschka; Olga Ilinskaya
Journal:  Biomed Res Int       Date:  2017-05-04       Impact factor: 3.411

8.  NS Segment of a 1918 Influenza A Virus-Descendent Enhances Replication of H1N1pdm09 and Virus-Induced Cellular Immune Response in Mammalian and Avian Systems.

Authors:  Henning Petersen; Ahmed Mostafa; Mohamed A Tantawy; Azeem A Iqbal; Donata Hoffmann; Aravind Tallam; Balachandar Selvakumar; Frank Pessler; Martin Beer; Silke Rautenschlein; Stephan Pleschka
Journal:  Front Microbiol       Date:  2018-03-22       Impact factor: 5.640

Review 9.  Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview.

Authors:  Ahmed Mostafa; Elsayed M Abdelwhab; Thomas C Mettenleiter; Stephan Pleschka
Journal:  Viruses       Date:  2018-09-13       Impact factor: 5.048

10.  Evolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015.

Authors:  Sara Hussein Mahmoud; Ahmed Mostafa; Rabeh El-Shesheny; Mohamed Zakaraia Seddik; Galal Khalafalla; Mahmoud Shehata; Ahmed Kandeil; Stephan Pleschka; Ghazi Kayali; Richard Webby; Veljko Veljkovic; Mohamed Ahmed Ali
Journal:  Pathogens       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.